Literature DB >> 8607229

The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter.

M J Edelman1, P Potter, K G Mahaffey, R Frink, R B Leidich.   

Abstract

OBJECTIVES: Intraoperative autotransfusion of shed blood is widely utilized in surgery. However, several studies have raised concern about the transmission of tumor cells during oncologic procedures. We compared the ability of a leukocyte depletion filter (RC-400; LDF) to a standard red blood cell filter (SBF) to remove tumor cells derived from urologic malignancies.
METHODS: Cells were suspended in media and passed through a SBF or a LDF. The filtrate was evaluated for the presence of viable cells utilizing the trypan blue exclusion method as well as cell culture. In a second experiment, cells were suspended in fresh bovine blood and processed through a cell saver apparatus followed by filtration with either a SBF or a LDF. Aliquots were cultured after admixture with blood, after processing, and after filtration.
RESULTS: The LDF was able to remove tumor cells completely, as demonstrated by both counting with the trypan blue exclusion test and by cell culture. In contrast, admixture with blood processing through the cell saver apparatus nor a standard red blood cell filter removed these cells.
CONCLUSIONS: Tumor cells derived from urologic malignancies are easily removed with a LDF but not with a SBF. Filtration of blood salvaged at the time of uro-oncologic surgery with a LDF but not with a SBF reduces the potential for reinfusion of viable tumor cells.

Entities:  

Mesh:

Year:  1996        PMID: 8607229     DOI: 10.1016/S0090-4295(99)80411-7

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  16 in total

Review 1.  Transfusion of post-operative shed blood: laboratory characteristics and clinical utility.

Authors:  M Muñoz; J J García-Vallejo; M D Ruiz; R Romero; E Olalla; C Sebastián
Journal:  Eur Spine J       Date:  2004-05-08       Impact factor: 3.134

2.  Intraoperative red blood cell salvage and autologous transfusion during open radical retropubic prostatectomy: a cost-benefit analysis.

Authors:  Sarvpreet Ubee; Manal Kumar; Nallaswami Athmanathan; Gurpreet Singh; Sean Vesey
Journal:  Ann R Coll Surg Engl       Date:  2011-03       Impact factor: 1.891

3.  Peri-operative filtration of disseminated cytokeratin positive cells in patients with colorectal liver metastasis.

Authors:  Nils R Frühauf; Sabine Kasimir-Bauer; Klaus Görlinger; Hauke Lang; Christian P Kaudel; Gernot M Kaiser; Karl J Oldhafer; Christoph E Broelsch
Journal:  Langenbecks Arch Surg       Date:  2004-11-19       Impact factor: 3.445

4.  Washing and filtering of cell-salvaged blood - does it make autotransfusion safer?

Authors:  Gerhardt Konig; Jonathan H Waters
Journal:  Transfus Altern Transfus Med       Date:  2012-12-01

Review 5.  Intra-operative cell salvage: a fresh look at the indications and contraindications.

Authors:  Stephen A Esper; Jonathan H Waters
Journal:  Blood Transfus       Date:  2011-01-13       Impact factor: 3.443

6.  The use of intraoperative cell salvage in urologic oncology.

Authors:  Matthew C Ferroni; Andres F Correa; Timothy D Lyon; Benjamin J Davies; Michael C Ost
Journal:  Rev Urol       Date:  2017

7.  Cisplatin combined with hyperthermia kills HepG2 cells in intraoperative blood salvage but preserves the function of erythrocytes.

Authors:  Jin-ting Yang; Li-hui Tang; Yun-qing Liu; Yin Wang; Lie-ju Wang; Feng-jiang Zhang; Min Yan
Journal:  J Zhejiang Univ Sci B       Date:  2015-05       Impact factor: 3.066

8.  Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence?

Authors:  Raphael Lc Araujo; Carlos Andrés Pantanali; Luciana Haddad; Joel Avancini Rocha Filho; Luiz Augusto Carneiro D'Albuquerque; Wellington Andraus
Journal:  World J Gastrointest Surg       Date:  2016-02-27

9.  Blood salvage and cancer surgery: should we do it?

Authors:  Jonathan H Waters; Albert D Donnenberg
Journal:  Transfusion       Date:  2009-10       Impact factor: 3.157

10.  Person-to-Person Cancer Transmission via Allogenic Blood Transfusion.

Authors:  Eugen Molodysky; Ross Grant
Journal:  Asian Pac J Cancer Prev       Date:  2021-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.